ReviewIn vivo (Athens, Greece)

Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract.

Fuchun Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.